Gene · 2487
Papers2,278
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,278
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of "Tobacco Free" Language in Warning Labels on Perceptions of Electronic Cigarettes and Nicotine Pouches among Young Adult Men: A Randomized Trial. | Subst Use Misuse | 2023 | 37227265 | PubTator, text mining | PubMed |
| Characterization and selection of probiotic lactic acid bacteria from different dietary sources for development of functional foods. | Front Microbiol | 2023 | 37213505 | PubTator, text mining | PubMed |
| Role of smoothened and sfrp genes in Eupentacta fraudatrix regeneration. | Wound Repair Regen | 2023 | 37210604 | PubTator, text mining | PubMed |
| Targeting strategies for bone diseases: signaling pathways and clinical studies. | Signal Transduct Target Ther | 2023 | 37198232 | PubTator, text mining | PubMed |
| Association of muscular strength and targeted proteomics involved in brain health in children with overweight/obesity. | Scand J Med Sci Sports | 2023 | 37190796 | PubTator, text mining | PubMed |
| The Multifaceted Role of WNT Signaling in Alzheimer's Disease Onset and Age-Related Progression. | Cells | 2023 | 37190113 | PubTator, text mining | PubMed |
| Integrative Analysis and Experimental Validation of Competing Endogenous RNAs in Obstructive Sleep Apnea. | Biomolecules | 2023 | 37189386 | PubTator, text mining | PubMed |
| Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers. | Int J Mol Sci | 2023 | 37176108 | PubTator, text mining | PubMed |
| Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies-An Update Overview. | Molecules | 2023 | 37175156 | PubTator, text mining | PubMed |
| Fracture healing-orthobiologics: from basic science to clinical application. | OTA Int | 2023 | 37168028 | PubTator, text mining | PubMed |
| Finding Excited-State Minimum Energy Crossing Points on a Budget: Non-Self-Consistent Tight-Binding Methods. | J Phys Chem Lett | 2023 | 37144783 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses. | Mediators Inflamm | 2023 | 37144239 | PubTator, text mining | PubMed |
| Research Progress on Mesenchymal Stem Cells for the Treatment of Diabetes and Its Complications. | Int J Endocrinol | 2023 | 37143697 | PubTator, text mining | PubMed |
| Warning Signs From the Crypt: Aberrant Protein Glycosylation Marks Opportunities for Early Colorectal Cancer Detection. | Clin Transl Gastroenterol | 2023 | 37141103 | PubTator, text mining | PubMed |
| Altered zinc homeostasis in a primary cell culture model of the retinal pigment epithelium. | Front Nutr | 2023 | 37139441 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of the ocular anterior segment: a comprehensive review. | Eye (Lond) | 2023 | 37138096 | PubTator, text mining | PubMed |
| Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells. | Exp Mol Med | 2023 | 37121972 | PubTator, text mining | PubMed |
| Evidence implicating sequential commitment of the founder lineages in the human blastocyst by order of hypoblast gene activation. | Development | 2023 | 37102672 | PubTator, text mining | PubMed |
| Contribution of S100A4-expressing fibroblasts to anti-SSA/Ro-associated atrioventricular nodal calcification and soluble S100A4 as a biomarker of clinical severity. | Front Immunol | 2023 | 37090702 | PubTator, text mining | PubMed |
| A beginner's guide on the use of brain organoids for neuroscientists: a systematic review. | Stem Cell Res Ther | 2023 | 37061699 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2487/papers?page=12